The Vinnova project BRIDGE Sweden is receiving a 7.7 million SEK investment to streamline the transition from research to commercialization of biological pharmaceuticals and precision medicine. The initiative aims to integrate research infrastructure with innovation systems, develop new cell lines on SciLifeLab's DDD platform, and enhance Sweden's global position in drug development.
Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.